105 results
8-K
EX-99.1
NVRO
Nevro Corp
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
.
Nevro to Participate in J.P. Morgan 42nd Annual Healthcare Conference
As previously announced, members of Nevro’s management team will participate … in the J.P. Morgan 42nd Annual Healthcare Conference on Thursday, January 11, 2024. The company’s formal presentation will begin at 8:15 am PST (11:15 am
8-K
EX-10.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
or vested with the authority to administer or enforce, any Healthcare Laws.
“Guaranty” of or by any Person (the “guarantor”) means any obligation … ) any material classified or regulated as “hazardous” or “toxic” or words of like import pursuant to an Environmental Law.
“Healthcare Laws” means
8-K
EX-2.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
(a) or (b), or any similar law, rule or regulation of any other Governmental Entities, (B) debarment, suspension, or exclusion under any federal healthcare … ), the Medicaid statute (Title XIX of the Social Security Act) and any other Law pertaining to or governing a government healthcare program, the federal Anti
8-K
7xys3
7 Jul 23
Departure of Directors or Certain Officers
4:37pm
8-K
EX-99.1
c4aglj9w
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
8-K
3o7g5578
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
avlhd6nd6cnopf
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
cbkdqokyk6snc
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm